Skip to main content

Table 1 Correlation between CPNE1 mRNA expression and OS and RFS in HCC based on different clinical parameters by Kaplan–Meier plotter

From: CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma

Clinical characteristics

OS (N = 364)

RFS (N = 316)

N

HR

P-value

N

HR

P-value

Gender

      

 Female

118

1.7 (0.97–3)

0.063

106

2.02 (1.11–3.66)

0.019

 Male

246

1.74 (1.12–2.71)

0.013

210

0.66 (0.43–1.02)

0.061

Stage

      

 I

170

1.66 (0.83–3.32)

0.15

153

0.81 (0.47–1.41)

0.46

 II

83

2.24 (1–5.03)

0.045

75

0.48 (0.23–0.98)

0.039

 III

83

2.53 (1.37–4.86)

0.0022

70

2.04 (1.08–3.85)

0.026

 IV

4

NA

NA

0

NA

NA

Grade

      

 1

55

3.16 (1.19–8.41)

0.015

45

4.1 (1.48–11.38)

0.0036

 2

174

1.77 (1.06–2.96)

0.027

149

1.62 (0.99–2.65)

0.055

 3

118

1.64 (0.89–3.05)

0.11

107

0.67 (0.39–1.17)

0.16

 4

12

NA

NA

11

NA

NA

Hepatitis virus

      

 Yes

150

1.28 (0.67–2.45)

0.46

139

0.6 (0.35–1.01)

0.053

 None

167

1.85 (1.15–2.96)

0.0097

143

2.22 (1.33–3.71)

0.0017

Alcohol consumption

      

 Yes

115

2.3 (1.18–4.49)

0.012

99

0.65 (0.33–1.29)

0.22

 None

202

1.83 (1–3.34)

0.046

183

1.56 (1–2.45)

0.05

  1. OS Overall Survival, RFS Relapse Free Survival, HR Hazard ratio